Linzess Description

Manufacturer:

Distributor:

Marketer:

AstraZeneca

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each hard capsule contains 290 mcg of linactolide.
Excipients/Inactive Ingredients: Capsule contents: Cellulose, microcrystalline; Hypromellose; Calcium chloride dihydrate; Leucine.
Capsule shell: Titanium dioxide (E171); Gelatin; Red iron oxide (E172); Yellow iron oxide (E172).
Capsule ink: Shellac; Propylene glycol; Ammonia solution, concentrated; Potassium hydroxide; Titanium dioxide (E 171); Black iron oxide (E172).

Exclusive offer for doctors

Already a member? Sign in